Simplify Medical, Inc. Announces First Patient Treated In U.S. Pivotal Trial Of MRI-Optimized Simplify Cervical Artifical Spinal Disc Used At Two Adjacent Levels Post author:Sam Post published:April 11, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Sarepta to Seek FDA Approval for Second DMD Treatment March 11, 2018 Vexim Strengthens Its Intellectual Property Protection For The SpineJack In Asia: Two Patents Granted In China And Japan February 1, 2017 REGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships January 8, 2018
Vexim Strengthens Its Intellectual Property Protection For The SpineJack In Asia: Two Patents Granted In China And Japan February 1, 2017